De novo Angiosarcoma of a Renal Allograft

被引：1
|
作者：
Ferroni, Matthew C. [1 ]
Ristau, Benjamin T. [1 ]
Jackman, Stephen V. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Dept Urol, Pittsburgh, PA 15213 USA
来源：
UROLOGIA INTERNATIONALIS | 2015年 / 95卷 / 03期
关键词：
Renal transplantation; Angiosarcoma; Immunosuppression; Gross hematuria;
D O I：
10.1159/000354413
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Prolonged exposure to immunosuppressive medication is a known risk factor for the development of post-transplant malignancies. De novo angiosarcoma in the post-transplant population is extremely rare. We present an 81-year-old female who developed an angiosarcoma at the site of a functioning renal allograft and review contemporary treatment strategies for this devastating disease. The report underscores the importance of periodic surveillance for the development of malignancy in the immunosuppressed population. (C) 2014 S. Karger AG, Basel
引用
收藏
页码：367 / 369
页数：3
相关论文
共 50 条
  • [1] De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression
    Rachelle Asciak
    Jesmar Buttigieg
    Louis Buhagiar
    CEN Case Reports, 2016, 5 (1) : 99 - 102
  • [2] De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppression
    Asciak, Rachelle
    Buttigieg, Jesmar
    Buhagiar, Louis
    CEN CASE REPORTS, 2016, 5 (01): : 99 - 102
  • [3] De novo angiosarcoma of the bladder: A case report
    Pierce, Daniel
    Connelly, Zachary M.
    Boyd, Frank
    Heinsimer, Kevin
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2023, 11
  • [4] NFAT-regulated gene expression in de novo renal allograft recipients
    Sommerer, C.
    Zeier, M.
    Meuer, S.
    Giese, T.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 476 - 476
  • [5] De novo light-chain deposition disease in a cadaver renal allograft
    Ecder, T
    Tbakhi, A
    Braun, WE
    Tubbs, RR
    Myles, J
    McMahon, JT
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (03) : 461 - 465
  • [6] Incidence and clinical course of de-novo malignancies in renal allograft recipients
    Winkelhorst, JT
    Brokelman, WJ
    Tiggeler, RG
    Wobbes, T
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (04): : 409 - 413
  • [7] Recurrent and de novo disease after renal transplantation:: A report from the Renal Allograft Disease Registry
    Hariharan, S
    Savin, VJ
    PEDIATRIC TRANSPLANTATION, 2004, 8 (04) : 349 - 350
  • [8] Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A
    Sommerer, Claudia
    Zeier, Martin
    Meuer, Stefan
    Giese, Thomas
    CLINICAL NEPHROLOGY, 2015, 84 (03) : 165 - 172
  • [9] Disseminated angiosarcoma presenting as a hemophagocytic syndrome in a renal allograft recipient
    Dargent, JL
    Vermylen, P
    Abramowicz, D
    Lespagnard, L
    Cochaux, P
    Capel, P
    Velu, T
    Vereerstraeten, P
    Haot, J
    DeWolfPeeters, C
    TRANSPLANT INTERNATIONAL, 1997, 10 (01) : 61 - 64
  • [10] De novo tumours of renal transplants
    Hetet, J. -F.
    Rigaud, J.
    Theo, M. Dore-Le
    Leaute, F.
    Karam, G.
    Blanchet, P.
    ANNALES D UROLOGIE, 2007, 41 (06) : 285 - 297
12345